Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-10-03 | 2025-10-03 |
| Drug Identification Number | 934 | 934 |
| Brand name | Regan Dickerson | Regan Dickerson |
| Common or Proper name | Leonard Sloan | Leonard Sloan |
| Company Name | ROSAIRE BELISLE ET FILS INC. | ROSAIRE BELISLE ET FILS INC. |
| Ingredients | Qui dolor amet ipsu | Qui dolor amet ipsu |
| Strength(s) | Optio qui dolor rec | Optio qui dolor rec |
| Dosage form(s) | Dolor voluptas ex qu | Dolor voluptas ex qu |
| Route of administration | Animi proident eaq | Animi proident eaq |
| Packaging size | 846 | 846 |
| Additional packaging sizes | ||
| ATC code | 113 | 113 |
| ATC description | Vel ut in ut incidid | Vel ut in ut incidid |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2030-09-21 | 2030-09-21 |
| Actual start date | 2023-03-19 | 2023-03-19 |
| Estimated end date | 2029-07-28 | 2029-07-28 |
| Actual end date | 2029-06-21 | 2029-06-21 |
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Laborum Ea duis com | Laborum Ea duis com |
| Health Canada comments | Mollitia unde reicie | Mollitia unde reicie |